Dose-ranging Study to Evaluate the Effectiveness and Tolerability of MK0736 in Patients With Type 2 Diabetes Mellitus (T2DM) and Hypertension (0736-007)

NCT00806585 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

620

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus
Hypertension

Interventions

DRUG: MK-0736
DRUG: Comparator: Placebo
DRUG: Comparator: HCTZ

Sponsor

Merck Sharp & Dohme LLC